Protective packaging is easy to treat as a minor consumable — until a shortage delays dispatch. When the product can’t ship without it, packaging becomes part of the supply chain itself. That’s why availability, responsiveness and local manufacturing deserve a place in the conversation about supply-chain resilience.
Your product is finished.
Your customer is waiting.
But you can’t ship because the packaging hasn’t arrived.
At that point, packaging isn’t just a consumable.
It’s a critical supply-chain input.
That distinction matters more than many businesses realise.
Protective packaging is often treated as a relatively minor procurement item. Compared with raw materials, machinery, freight, labour or the product itself, it can look like a small line item.
But its real importance isn’t determined by how much it costs.
It’s determined by what happens when you don’t have it.
For manufacturers, food producers, pharmaceutical suppliers and businesses shipping sensitive or high-value products, the wrong packaging — or no packaging — can stop an otherwise finished order from leaving the building.
And that makes packaging supply something worth thinking about strategically.
The cheapest input can still create an expensive problem
The cheapest input can still create an expensive problem
Supply-chain risk is not simply about the monetary value of an item.
The Australian Productivity Commission has looked at vulnerable supply chains through a much more useful lens: how easily an input can be substituted and whether production can continue without it.
That’s important because some relatively inexpensive items can become operational bottlenecks.
Protective packaging is a good example.
A manufacturer may have completed a $20,000 component, but if the specified surface protection needed to transport it safely isn’t available, shipping it unprotected is hardly a sensible alternative.
A seafood supplier may have a product ready for dispatch, but still require the correct thermal liner and gel-pack configuration.
A pharmaceutical supplier dealing with temperature-sensitive medicines cannot simply substitute any available packaging and assume the cold chain will perform in the same way.
In other words:
The value of packaging isn’t just what you pay for it. It’s what depends on it.
Packaging has its own supply chain
This is easy to overlook.
Businesses tend to think about packaging as the end of their supply chain.
But packaging manufacturers and suppliers have supply chains too.
Plastic resins, films, additives, components, energy, freight, machinery and manufacturing capacity can all influence availability.
In fact, in 2026 the Australian Government specifically identified polymer and plastic resin supply as an area being monitored through its supply-chain resilience work.
Australian food and grocery manufacturers have also identified packaging availability alongside freight, ingredients, pallets, labour and port disruption as an operational issue.
That should tell procurement teams something important.
Packaging supply isn’t immune from the same pressures affecting other inputs.
Global freight disruption, raw-material shortages, geopolitical events, production constraints and sudden changes in demand can all work their way down the chain.
And Australia’s distance from many major manufacturing centres adds another variable.
None of this means imported packaging is a poor choice.
It means the length and flexibility of the supply chain should form part of the buying decision.
This becomes even more important with food and perishables
When a product has a limited shelf life, time matters.
Australia’s Department of Agriculture has previously estimated that deficiencies and breaks in the cold food chain contribute to billions of dollars in food waste across fruit and vegetables, meat, seafood and dairy.
That loss isn’t caused simply by packaging.
Cold-chain performance depends on refrigeration, loading, handling, transport, storage, transfer points and many other factors.
But that’s precisely the point.
Temperature-sensitive distribution is a system.
Packaging forms part of that system.
A thermal liner, gel pack, insulated cover or other protective format may need to perform for a particular journey duration, ambient condition or distribution method.
If the required packaging suddenly isn’t available, the problem isn’t solved simply by finding something else that looks similar.
That substitute still has to perform.
And when the product is perishable, businesses don’t always have the luxury of waiting several weeks to find out.
Pharmaceutical supply chains raise the stakes further
The same principle applies in healthcare, but often with even tighter requirements.
Australian TGA guidance recognises the role of validated temperature-control systems, including thermal packaging, in maintaining medicine integrity during distribution.
Packaging selection can depend on factors including transit time, environmental conditions and expected temperature exposure.
Australia’s vaccine-storage guidance similarly places strong emphasis on maintaining the required temperature range during storage and transport.
That changes the procurement conversation.
For a temperature-sensitive pharmaceutical shipment, the question isn’t simply:
“Can we get another liner?”
It may be:
“Can we get another solution that we know will perform appropriately within this distribution system?”
That’s a much harder question to answer at the last minute.
Which is why availability, communication, technical understanding and responsiveness matter alongside price.
So where does local manufacturing fit?
This is where the argument for local manufacturing becomes more interesting.
Not because “Australian made” automatically means better.
And certainly not because domestic manufacturing somehow removes every supply-chain risk.
It doesn’t.
Australian manufacturers can still rely on imported raw materials. They still deal with capacity constraints, transport issues and changes in demand.
But local manufacturing can shorten and simplify part of the supply chain between the producer and the customer.
That can matter in several ways.
A customer may have more direct access to the people actually making or converting the packaging.
Specifications can potentially be discussed and adjusted more quickly.
Lead times may be less exposed to international freight.
Custom formats can be produced closer to where they will be used.
And when volumes change unexpectedly, a local manufacturing relationship may provide more scope to understand what is actually possible rather than waiting for the next offshore shipment.
The advantage isn’t nationalism.
It’s flexibility.
Resilient supply chains aren’t about putting everything onshore
There’s an important qualification here.
The answer to global supply-chain risk isn’t necessarily to manufacture everything domestically.
OECD research into supply-chain resilience has found strong benefits from supplier diversification, while suggesting that onshoring alone does not eliminate vulnerability.
That makes sense.
Moving dependency from one supplier to another doesn’t automatically make a supply chain resilient.
Good risk management may include a combination of local production, imported supply, alternative suppliers, appropriate stockholding, flexible specifications and contingency planning.
Local manufacturing is simply one more lever.
But for an input that can stop dispatch, it can be a valuable one.
The procurement question worth asking
Many businesses negotiate hard over packaging price.
That’s completely reasonable.
But price shouldn’t be the only number in the conversation.
There’s another calculation:
What does it cost if the packaging isn’t there when we need it?
That might include delayed dispatch, idle staff, interrupted production, missed delivery windows, expedited freight, product damage, temperature excursions, wasted stock or disappointed customers.
Suddenly, saving a few cents per unit can look very different if the supply model introduces another point of vulnerability.
For critical packaging, procurement teams may want to ask:
• How long could we operate if supply stopped tomorrow?
• How quickly could our supplier replenish us?
• Are suitable alternatives already identified?
• Would those alternatives need testing or validation?
• Can the packaging specification be modified locally?
• Who do we speak to if demand suddenly doubles?
• How much safety stock is appropriate?
• Are we dependent on one supplier, one country or one freight route?
• What does one day of delayed dispatch actually cost us?
Those are supply-chain questions.
Not simply packaging questions.
Protective packaging protects more than the product
Sancell has manufactured protective packaging in Australia since 1988, including bubble and foam protection, cold-chain packaging, gel packs, padded mailers and custom protective solutions.
The benefit of manufacturing locally isn’t simply being able to put an Australian-made statement beside a product.
It’s having manufacturing capability, packaging knowledge and production closer to the businesses relying on it.
That can be particularly valuable when a business needs something customised, volumes change, specifications evolve or continuity of supply becomes important.
Because protective packaging has one obvious job:
protect the product.
But the right packaging supply strategy may also help protect something bigger:
the ability to keep that product moving.
And when a finished product cannot safely or practically ship without its packaging, that packaging is no longer just a consumable.
It becomes part of your supply-chain strategy.
Build More Resilience Into Your Packaging Supply
When protective packaging is critical to getting your product out the door, reliable supply matters.
Sancell manufactures protective packaging here in Australia, helping businesses respond to changing volumes, protection requirements and supply-chain pressures with solutions designed for the job.
Talk to Sancell about the protective packaging your products and supply chain depend on.
References:
• Australian Government, Department of Industry – Office of Supply Chain Resilience / Manufacturing Australia’s Future, May 2026.
https://www.industry.gov.au/trade/office-supply-chain-resilience
• Australian Productivity Commission – Vulnerable Supply Chains, 2021.
https://assets.pc.gov.au/inquiries/completed/supply-chains/report/supply-chains-overview.pdf
• Australian Government Department of Agriculture – A Study of Waste in the Cold Food Chain. https://www.agriculture.gov.au/sites/default/files/documents/study-of-waste-in-cold-food-chain-and-opportunities-improvement.pdf
• TGA – Australian Code of Good Wholesaling Practice for Medicines.
https://www.tga.gov.au/resources/publication/corporate-reports/australian-code-good-wholesaling-practice-medicines-schedules-2-3-4-8
• Australian Department of Health – National Vaccine Storage Guidelines, 2025.
https://www.health.gov.au/resources/publications/national-vaccine-storage-guidelines-strive-for-5?
• Australian Food & Grocery Council – Supply Chain Disruptions Survey and May 2026 industry update.
https://afgc.org.au/reports/supply-chain-disruptions-survey/
• OECD – Policies to Strengthen the Resilience of Global Value Chains, 2023.
https://www.oecd.org/en/publications/policies-to-strengthen-the-resilience-of-global-value-chains_fd82abd4-en.html
• US FDA – Drug Shortages.
https://www.fda.gov/drugs/drug-shortages/frequently-asked-questions-about-drug-shortages